Cleared Traditional

K133758 - CENTERVUE MACULAR INTEGRITY ASSESSMENT

K133758 is an FDA 510(k) clearance for CENTERVUE MACULAR INTEGRITY ASSESSMENT, manufactured by Centervue S.P.A.. The device is a Class 2 Ophthalmic device with product code HLI cleared through the Traditional 510(k) pathway after a 133-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2014
Decision
133d
Days
Class 2
Risk

K133758 is an FDA 510(k) clearance for the CENTERVUE MACULAR INTEGRITY ASSESSMENT. Classified as Ophthalmoscope, Ac-powered (product code HLI), Class II - Special Controls.

Submitted by Centervue S.P.A. (Rome, IT). The FDA issued a Cleared decision on April 23, 2014 after a review of 133 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.1570 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Centervue S.P.A. devices

FDA 510(k) Submission Details - K133758

510(k) Number K133758 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 11, 2013
Decision Date April 23, 2014
Days to Decision 133 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
23d slower than avg
Panel avg: 110d · This submission: 133d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HLI Device Classification - Class 2, Special Controls

Product Code HLI Ophthalmoscope, Ac-powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.1570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HLI Ophthalmoscope, Ac-powered

All 35
Devices cleared under the same product code (HLI) and FDA review panel - the closest regulatory comparables to K133758.
CIRRUS HD-OCT, MODEL 4000
K063378 · Carl Zeiss Meditec, Inc. · Jan 2007
VANTAGE INDIRECT OPHTHALMOSCOPE
K060822 · Keeler Instruments, Inc. · May 2006
VISANTE OCT
K051789 · Carl Zeiss Meditec, Inc. · Sep 2005
STRATUSOCT WITH RNFL & MACULA NORMATIVE DATABASE
K033123 · Carl Zeiss Meditec, Inc. · Apr 2004
STRATUSOCT WITH RNFL NORMATIVE DATABASE
K030433 · Carl Zeiss Meditec, Inc. · May 2003
WELCH ALLYN 11800 OPTHALMOSCOPE
K003376 · Welch Allyn, Inc. · Jan 2001